VT3989

· Vivace Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VT3989, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors [Phase 1, Phase 2]